Benchmark Investment Advisors LLC Novartis Ag Transaction History

Benchmark Investment Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $257,610 - $293,302	-2,704 Closed	0 $0
Q4 2023 May 15, 2024	BUY	$92.27 - $101.54 $249,498 - $274,564	2,704 New	2,704 $273,000
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $2,841 - $3,153	-30 Reduced 0.89%	3,344 $340,000
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $18,133 - $20,562	-196 Reduced 5.49%	3,374 $340,000
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $4,961 - $5,754	-62 Reduced 1.71%	3,570 $328,000
Q4 2022 Feb 21, 2023	SELL	$75.55 - $92.52 $35,886 - $43,947	-475 Reduced 11.57%	3,632 $329,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $19,100 - $22,338	-256 Reduced 5.87%	4,107 $312,000
Q2 2022 Aug 08, 2022	SELL	$80.52 - $93.75 $40,260 - $46,875	-500 Reduced 10.28%	4,363 $369,000
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $45,422 - $51,381	-567 Reduced 10.44%	4,863 $427,000
Q4 2021 Feb 16, 2022	BUY	$79.7 - $88.13 $432,771 - $478,545	5,430 New	5,430 $475,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Benchmark Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Benchmark Investment Advisors LLC with notifications on news.